J. Georges Youssef, MD

Projects

Projects per year 2020 2020 2021 2022 2022

• 1 Finished
• 2 Not started
• 4 Active

Projects per year

Search results

• Active

  A Randomized Controlled Open-label Study to Assess the Safety and Tolerability of Nebulized PC945 for Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients

  Goodarzi, A., Long, S. W., Yau, S. W. & Youssef, J. G.

  2/15/22 → …

  Project: Clinical Trial

• Mitochondrial function in symptomatic chronic COVID-19 patients COVID-19 Associated Mitochondria Functional Changes in Subjects with Post-Acute Sequelae of SARS-CoV-2 Infections (PASC)

  Hamilton, D. J., Kansara, A. & Youssef, J. G.

  6/16/21 → …

  Project: Clinical Trial

• Clazakizumab - COVID-19

  Gaber, A. O., Goodarzi, A., Graviss, E. A., Moore, L. W., Yau, S. W., Youssef, J. G. & Zahiruddin, F.

  7/8/20 → …

  Project: Clinical Trial

• A Phase III, Multicenter, Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care in the Treatment of Bronchiolitis Obliterans Syndrome in Patients post Single or Double Lung Transplantation (BT-L-CsA-303-FU (BOSTON-3))

  Goodarzi, A., Yau, S. W. & Youssef, J. G.

  5/27/20 → …

  Project: Clinical Trial

• Not started

  A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

  Goodarzi, A., Yau, S. W. & Youssef, J. G.

  Project: Clinical Trial

• A Randomized Double Blind, Placebo-Controlled Study of Auxora for the Treatment of Severe COVID-19 Pneumonia (CARDEA) - Pregnancy Reporting of Male Study Subject's Partner

  Youssef, J. G.

  Project: Clinical Trial

• Finished

  A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients with Acute Respiratory Distress Syndrome Associated with COVID-19 (Therapeutics for Severely Ill Inpatients

  Youssef, J. G. & Zahiruddin, F.

  9/15/21 → 2/28/22

  Project: Non Profit